The current consensus estimates for BSX's forthcoming earnings report stand at $0.72 per share on revenue of $4.89 billion.

Boston Scientific stock has gained 57% in 2024 but the average analyst price target sits at 101.06, according to FactSet. That represents a further 11% upside for BSX as it looks to forge a new ...

Boston Scientific stock (NYSE: BSX) has seen a fall of 3% in a month, ... Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.

Boston Scientific Corp. closed 2.98% short of its 52-week high of $107.53, which the company achieved on June 30th.

Boston Scientific Corp.’s stock rose 7% Wednesday to put it on track for a fresh record high after the medical-tech company beat analyst estimates for first-quarter earnings and offered upbeat ...

Boston Scientific stock (NYSE: BSX) has seen a fall of 3% in a month, compared with -5% returns for the broader S&P500 index. The company reported mixed Q4 results last month, with revenue falling ...